Increased oxidative stress and depleted antioxidant capacity in chronic obstructive pulmonary disease: Searching for applications.
作者信息
Agrawal Anurag
机构信息
CSIR-Institute of Genomics and Integrative Biology, Delhi University, New Delhi, India.
出版信息
Lung India. 2017 Jul-Aug;34(4):309-310. doi: 10.4103/lungindia.lungindia_223_17.
Abstract
摘要
相似文献
1
Increased oxidative stress and depleted antioxidant capacity in chronic obstructive pulmonary disease: Searching for applications.
Lung India. 2017 Jul-Aug;34(4):309-310. doi: 10.4103/lungindia.lungindia_223_17.
2
Oxidant metabolism in chronic obstructive pulmonary disease.
Eur Respir J Suppl. 2003 Nov;46:14s-27s. doi: 10.1183/09031936.03.00000403a.
3
Study of oxidative stress biomarkers in chronic obstructive pulmonary disease and their correlation with disease severity in north Indian population cohort.
Lung India. 2017 Jul-Aug;34(4):324-329. doi: 10.4103/lungindia.lungindia_205_16.
4
Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion.
Arch Phys Med Rehabil. 2013 Aug;94(8):1607-14. doi: 10.1016/j.apmr.2013.02.005. Epub 2013 Feb 14.
5
Role of oxidative stress and serum lipid levels in stable chronic obstructive pulmonary disease.
J Chin Med Assoc. 2015 Dec;78(12):702-8. doi: 10.1016/j.jcma.2015.08.004. Epub 2015 Oct 1.
6
Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats.
Exp Biol Med (Maywood). 2017 Sep;242(15):1534-1541. doi: 10.1177/1535370217725249. Epub 2017 Aug 10.
7
Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets.
Curr Drug Targets Inflamm Allergy. 2002 Sep;1(3):291-315. doi: 10.2174/1568010023344607.
8
Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?
Thorax. 2000 Mar;55(3):189-93. doi: 10.1136/thorax.55.3.189.
9
Decreased activity of butyrylcholinesterase in blood plasma of patients with chronic obstructive pulmonary disease.
Arch Med Sci. 2017 Apr 1;13(3):645-651. doi: 10.5114/aoms.2016.60760. Epub 2016 Jun 20.
10
Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
Respirology. 2013 Oct;18(7):1069-75. doi: 10.1111/resp.12118.
本文引用的文献
1
Study of oxidative stress biomarkers in chronic obstructive pulmonary disease and their correlation with disease severity in north Indian population cohort.
Lung India. 2017 Jul-Aug;34(4):324-329. doi: 10.4103/lungindia.lungindia_205_16.
2
Cancer, Oxidative Stress, and Metastasis.
Cold Spring Harb Symp Quant Biol. 2016;81:163-175. doi: 10.1101/sqb.2016.81.030791. Epub 2017 Jan 12.
3
Circulating biomarkers of oxidative stress in chronic obstructive pulmonary disease: a systematic review.
Respir Res. 2016 Nov 14;17(1):150. doi: 10.1186/s12931-016-0471-z.
4
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
5
Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Lancet Respir Med. 2014 Mar;2(3):187-94. doi: 10.1016/S2213-2600(13)70286-8. Epub 2014 Jan 30.
6
Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.
Lung India. 2013 Jul;30(3):228-67. doi: 10.4103/0970-2113.116248.
7
Oxidative stress in COPD patients, smokers, and non-smokers.
Respir Care. 2012 Dec;57(12):2090-4. doi: 10.4187/respcare.01809.
8
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial.
Lancet. 2005;365(9470):1552-60. doi: 10.1016/S0140-6736(05)66456-2.
9
Protease-cleaved iron-transferrin augments oxidant-mediated endothelial cell injury via hydroxyl radical formation.
J Clin Invest. 1995 Jun;95(6):2491-500. doi: 10.1172/JCI117950.
10
Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation.
J Clin Invest. 1991 Oct;88(4):1092-102. doi: 10.1172/JCI115408.
Zotero 插件